Targeting neddylation as a novel approach to lung cancer treatment (Review)

Int J Oncol. 2023 May;62(5):65. doi: 10.3892/ijo.2023.5513. Epub 2023 Apr 21.

Abstract

As a protein that resembles ubiquitin, neural precursor cell expressed developmentally downregulated 8 (NEDD8) takes part in neddylation, which modifies substrates in a manner similar to ubiquitination and alters the activity of target proteins. Neddylation may affect the activity of multiple signaling pathways, have a regulatory role in tumor formation, progression and metastasis, and influence the prognosis of cancer treatment. The present review summarizes the regulatory roles of NEDD8 in the MDM2‑p53, NF‑κB, PI3K/AKT/mTOR, hypoxia‑inducible factor, Hippo and receptor tyrosine kinase signaling pathways, as well as in the development and progression of lung cancer.

Keywords: MLN4924; NEDD8; lung cancer; neddylation; signaling pathway; treatment.

Publication types

  • Review

MeSH terms

  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / pathology
  • NEDD8 Protein / genetics
  • NEDD8 Protein / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Ubiquitination
  • Ubiquitins*

Substances

  • Ubiquitins
  • NEDD8 Protein
  • Phosphatidylinositol 3-Kinases

Grants and funding

This research was supported by the National Natural Science Foundation of China (grant no. 81971088) and the Innovation Project of Shandong Academy of Medical Sciences, Shandong Provincial Natural Science Foundation, China (grant no. ZR2018MC008).